Why the study?
Does the presence of atrial fibrillation increase the risk of contrast-induced nephropathy in patients with NSTEMI undergoing PCI?
Does the presence of atrial fibrillation increase the risk of contrast-induced nephropathy in patients with NSTEMI undergoing PCI?
Atrial fibrillation is an independent predictor of contrast-induced nephropathy in patients with NSTEMI undergoing PCI.
Answers are grounded in this paper and cite their sources.
Identifies AF as a high-risk marker for contrast-induced nephropathy during NSTEM.
We investigated the relationship between atrial fibrillation (AF) and contrast-induced nephropathy (CIN) in patients with non-ST-segment elevation myocardial infarction (NSTEMI); 1045 consecutive patients undergoing percutaneous coronary interventions were enrolled. Risk factors for CIN were investigated. Baseline characteristics, except oral anticoagulant use, were similar between patients with and without AF. Patients with CIN show higher presence of diabetes mellitus (DM), coronary artery bypass graft surgery history, Mehran score, baseline creatinine levels, baseline glomerular filtration rate (GFR), peak troponin levels, left ventricular ejection fraction (LVEF), and presence of AF ( P < .05). In multivariate logistic regression analyses, the presence of DM (odds ratio [OR], 2.333; 95% confidence interval [CI], 1.222-4.457; P = .010), Mehran score (OR, 1.269; 95% CI, 1.152-1.398; P < .001), baseline GFR (OR, 0,954; 95% CI, 0.944-0.964 P < .001), left anterior descending artery originated infarction (OR, 1.594; 95% CI, 1.061-2.398; P = .025), LVEF value (OR, 0.956; 95% CI, 0.926-0.986; P = .005), and the presence of AF (OR, 3.830; 95% CI, 1.239-11.839; P = .020) were independent predictors of CIN. Atrial fibrillation can be related to CIN development in patients with NSTEMI.
No takes yet. Share an insight, caveat, or question.
Düzel et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: